HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine.

AbstractOBJECTIVES:
This study compared the effects of morning and evening dosing of amlodipine/valsartan combination on 24-h blood pressure (BP) in patients uncontrolled by amlodipine (5 mg).
METHODS:
This was a multicenter study that used a prospective, randomized, open-label, blinded endpoint design. Patients with essential hypertension, who's ambulatory BP was uncontrolled after 4 weeks on amlodipine (5 mg) were randomized to receive amlodipine/valsartan (5/160 mg) for 8 weeks in the morning or evening (n=231, 232, respectively), with optional uptitration up to 10/160 mg after 4 weeks if the office BP was uncontrolled. A 30-h ambulatory BP measurement was taken at randomization and at the end of the study.
RESULTS:
Morning and evening dosing with amlodipine/valsartan had equivalent effects on systolic BP (mean 24 h, daytime, night-time, and 24-30 h) and diastolic BP (mean 24 h, daytime, night-time, and 24-30 h). There was a small difference in the night-time diastolic BP (-4.92 vs.-6.20 mmHg; P=0.02) and a slight but nonsignificant trend for higher BP reduction during daytime for morning intake and during night-time for evening intake. BP control rates based on 24-h ambulatory BP measurement values (<120/80 mmHg) were similar between morning and evening dosing (47 vs. 45%).
CONCLUSION:
These results indicate that, in patients with BP uncontrolled by amlodipine (5 mg), morning and evening treatment with amlodipine/valsartan combination have similar effects on circadian BP, especially when 24-h mean values are considered.
AuthorsRoland Asmar, Philippe Gosse, Stéphane Queré, Assya Achouba
JournalBlood pressure monitoring (Blood Press Monit) Vol. 16 Issue 2 Pg. 80-6 (Apr 2011) ISSN: 1473-5725 [Electronic] England
PMID21372694 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Amlodipine, Valsartan Drug Combination
  • Antihypertensive Agents
  • Drug Combinations
  • Tetrazoles
  • Amlodipine
Topics
  • Aged
  • Amlodipine (administration & dosage, adverse effects, therapeutic use)
  • Amlodipine, Valsartan Drug Combination
  • Antihypertensive Agents (administration & dosage, adverse effects, therapeutic use)
  • Blood Pressure (drug effects)
  • Blood Pressure Monitoring, Ambulatory
  • Drug Chronotherapy
  • Drug Combinations
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Tetrazoles (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: